Pictet Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.1M | Buy |
1,093,378
+808,078
| +283% | +$44.4M | 0.06% | 293 |
|
|
2025
Q1 | $20.3M | Buy |
285,300
+600
| +0.2% | +$42.7K | 0.02% | 492 |
|
|
2024
Q4 | $18.7M | Sell |
284,700
-634,916
| -69% | -$41.7M | 0.02% | 522 |
|
|
2024
Q3 | $64.7M | Sell |
919,616
-743,547
| -45% | -$52.3M | 0.07% | 253 |
|
|
2024
Q2 | $137M | Sell |
1,663,163
-242,446
| -13% | -$20M | 0.16% | 159 |
|
|
2024
Q1 | $167M | Buy |
1,905,609
+468,886
| +33% | +$41M | 0.18% | 147 |
|
|
2023
Q4 | $139M | Sell |
1,436,723
-505,522
| -26% | -$48.7M | 0.15% | 168 |
|
|
2023
Q3 | $172M | Buy |
+1,942,245
| New | +$172M | 0.21% | 131 |
|